446
Participants
Start Date
June 30, 2022
Primary Completion Date
October 11, 2024
Study Completion Date
March 20, 2025
Amlitelimab
Injection solution Subcutaneous injection
Placebo
Injection solution Subcutaneous injection
Investigational Site Number : 3480007, Budapest
Investigational Site Number : 7100004, Middelburg
Investigational Site Number : 0320009, Buenos Aires
Investigational Site Number : 7100008, Johannesburg
Investigational Site Number : 7100007, Benoni
Investigational Site Number : 0320006, Rosario
Investigational Site Number : 3480011, Gödöllö
Investigational Site Number : 3480012, Százhalombatta
Investigational Site Number : 3480009, Edelény
Investigational Site Number : 7100003, Durban
Investigational Site Number : 3480002, Hajdunánás
Investigational Site Number : 3480006, Püspökladány
Investigational Site Number : 7100006, George
Investigational Site Number : 7100002, Cape Town
Investigational Site Number : 7100005, Cape Town
Investigational Site Number : 7100001, Cape Town
Investigational Site Number : 3480004, Mosonmagyaróvár
Investigational Site Number : 3480003, Szombathely
Investigational Site Number : 4100007, Seongnam-si, Gyeonggi-do
Johns Hopkins University School of Medicine Site Number : 8400012, Baltimore
Investigational Site Number : 4840002, Chihuahua City
Pines Care Research Center LLC Site Number : 8400028, Pembroke Pines
Investigational Site Number : 7920002, Mersin
Savin Medical Group, LLC Site Number : 8400015, Miami
Beautiful Minds Clinical Research Center Site Number : 8400027, Cutler Bay
Helix Biomedics, LLC Site Number : 8400029, Boynton Beach
Renaissance Research and Medical Group, Inc Site Number : 8400030, Cape Coral
Investigational Site Number : 4840004, Durango, Durango
Investigational Site Number : 7920001, Istanbul
Investigational Site Number : 7920003, Izmir
Investigational Site Number : 3800001, Verona
Investigational Site Number : 7920008, Kayseri
Investigational Site Number : 7920005, Kocaeli
Investigational Site Number : 4100004, Daegu
Asthma and Allergy Center Site Number : 8400005, Toledo
Investigational Site Number : 4840001, Guadalajara
Investigational Site Number : 3800002, Cona (FE)
Investigational Site Number : 4840005, Guadalajara
The South Bend Clinic, LLC Site Number : 8400033, South Bend
Headlands Research Detroit Site Number : 8400032, Southfield
Investigational Site Number : 4840006, Tlalnepantla
University of Kansas Medical Center Site Number : 8400016, Kansas City
OK Clinical Research, LLC Site Number : 8400001, Edmond
Allergy, Asthma and Clinical Research Center Site Number : 8400035, Oklahoma City
TTS Research Site Number : 8400011, Boerne
Investigational Site Number : 3800004, Napoli
Investigational Site Number : 6160002, Gdansk
Treasure Valley Medical Research Site Number : 8400031, Boise
Henderson Clinical Trials Site Number : 8400037, Henderson
California Allergy and Asthma Medical Group, Inc. Site Number : 8400002, Los Angeles
Allianz Research Institute Site Number : 8400023, Westminster
Allergy Asthma Associates of Santa Clara Valley Site Number : 8400019, San Jose
Bensch Clinical Research LLC Site Number : 8400004, Stockton
Investigational Site Number : 4840008, Yucatán
Investigational Site Number : 1520005, Quillota
Investigational Site Number : 1520007, Santiago
Investigational Site Number : 1520001, Santiago
Investigational Site Number : 1520002, Santiago
Investigational Site Number : 1520009, Santiago
Investigational Site Number : 1520008, Santiago
Investigational Site Number : 1520003, Santiago
University of California San Diego Health Site Number : 8400026, La Jolla
Reliable Clinical Research, LLC Site Number : 8400020, Hialeah
Investigational Site Number : 0320001, CABA
Investigational Site Number : 0320002, CABA
Investigational Site Number : 0320008, La Plata
Investigational Site Number : 0320007, Rosario
Investigational Site Number : 0320005, Rosario
Investigational Site Number : 0320004, Buenos Aires
Investigational Site Number : 0320003, Ciudad Autonoma Buenos Aires
CEDOES - Centro de Diagnostico e Pesquisa de Osteoporose do ES Site Number : 0760002, Vitória
Proar Site Number : 0760004, Salvador
Centro Avancado de Oncologia CECAN - Liga Contra o Cancer Site Number : 0760010, Natal
Instituto Mederi de Pesquisa e Saude Site Number : 0760001, Passo Fundo
Irmandade da Santa Casa de Misericordia de Porto Alegre Site Number : 0760007, Porto Alegre
Hospital Sao Lucas da PUCRS Site Number : 0760006, Porto Alegre
Hospital das Clinicas de Sao Paulo Site Number : 0760008, São Paulo
Clinica de Alergia Martti Antila Site Number : 0760003, Sorocaba
Investigational Site Number : 1240006, Brampton
Investigational Site Number : 1240008, Ottawa
Investigational Site Number : 1240005, Toronto
Investigational Site Number : 1240007, Trois-Rivières
Investigational Site Number : 1240003, Québec
Investigational Site Number : 1520006, Talca
Investigational Site Number : 4100006, Seoul
Investigational Site Number : 3800003, Rome
Investigational Site Number : 3920014, Narita-shi
Investigational Site Number : 3920002, Kamakura-shi
Investigational Site Number : 3920016, Yokohama
Investigational Site Number : 3920006, Yokohama
Investigational Site Number : 3920013, Nankoku-shi
Investigational Site Number : 3920015, Kumamoto
Investigational Site Number : 3920010, Sakai-shi
Investigational Site Number : 3920017, Chuo-ku
Investigational Site Number : 3920005, Chuo-ku
Investigational Site Number : 3920004, Chuo-ku
Investigational Site Number : 3920020, Kiyose-shi
Investigational Site Number : 3920001, Shinagawa-ku
Investigational Site Number : 3920011, Shinjuku-ku
Investigational Site Number : 3920009, Tachikawa-shi
Investigational Site Number : 3920018, Toshima-ku
Investigational Site Number : 3920008, Fukuoka
Investigational Site Number : 3920019, Hiroshima
Investigational Site Number : 6160001, Poznan
Investigational Site Number : 6160006, Krakow
Investigational Site Number : 6160004, Bialystok
Investigational Site Number : 6160003, Elblag
Investigational Site Number : 6160007, Tarnów
Investigational Site Number : 4100003, Seoul
Investigational Site Number : 4100001, Seoul
Investigational Site Number : 4100005, Seoul
Investigational Site Number : 4100002, Seoul
Investigational Site Number : 8260001, Bradford
Lead Sponsor
Sanofi
INDUSTRY